Attenuation of stunning by the calcium antagonist nisoldipine in patients with myocardial infarction and early percutaneous transluminal coronary angioplasty.
Heusch
G
G
Department of Pathophysiology, University of Essen Medical School, Germany.
D000800:Angioplasty, Balloon / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015737:Nisoldipine / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D015737:Nisoldipine